Patents by Inventor Huichao Luo

Huichao Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A TEIXOBACTIN ANALOGUE AND USE THEREOF
    Publication number: 20220273760
    Abstract: Pharmaceuticals, and specifically a Teixobactin analogue and use thereof. A pharmaceutical composition having the compound and use of the compound and the pharmaceutical composition thereof inhibits the growth and/or reproduction of Gram-positive bacteria or Mycobacterium tuberculosis.
    Type: Application
    Filed: July 23, 2020
    Publication date: September 1, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Qingyun REN, Zhimin XIONG, Yingjun ZHANG, Xuechen LI, Xianwu FU, Ali HUANG, Huichao LUO
  • Influenza virus replication inhibitor and use thereof
    Patent number: 11104689
    Abstract: Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: August 31, 2021
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Changhua Tang, Qingyun Ren, Huichao Luo, Junjun Yin, Kai Yi, Yibo Lei, Yejun Wang, Yingjun Zhang
  • INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF
    Publication number: 20200283454
    Abstract: Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.
    Type: Application
    Filed: September 18, 2018
    Publication date: September 10, 2020
    Applicants: SUNSHINE LAKE PHARMA CO., LTD., NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Changhua TANG, Qingyun REN, Huichao LUO, Junjun YIN, Kai YI, Yibo LEI, Yejun WANG, Yingjun ZHANG
  • Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
    Patent number: 9309231
    Abstract: Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: April 12, 2016
    Assignee: Sunshine Lake Pharma Co., Ltd.
    Inventors: Yingjun Zhang, Jiancun Zhang, Hongming Xie, Qingyun Ren, Yumei Tan, Huichao Luo
  • Spiro compounds as Hepatitis C virus inhibitors
    Patent number: 9303061
    Abstract: Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: April 5, 2016
    Assignee: Sunshine Luke Pharma Co., Ltd.
    Inventors: Jiancun Zhang, Yingjun Zhang, Hongming Xie, Qingyun Ren, Huichao Luo, Tianzhu Yu, Yumei Tan
  • SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
    Publication number: 20150232509
    Abstract: A compound of formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.
    Type: Application
    Filed: September 29, 2013
    Publication date: August 20, 2015
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Yingjun Zhang, Jiancun Zhang, Hongming Xie, Qingyun Ren, Xiwei Wu, Huichao Luo, Changping Fu, Bailin Hu, Shifeng Li, Changhua Tang, Yong Lei, Quanxing Yu, Qinghong Fang, Chenglin Wang
  • Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof
    Publication number: 20150079028
    Abstract: Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.
    Type: Application
    Filed: August 5, 2013
    Publication date: March 19, 2015
    Applicant: SUNSHINE LAKE PHARMA CO., LTD
    Inventors: Yingjun Zhang, Jaincun Zhang, Hongming Xie, Qingyun Ren, Yumei Tan, Huichao Luo
  • SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS
    Publication number: 20140147412
    Abstract: Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.
    Type: Application
    Filed: July 9, 2012
    Publication date: May 29, 2014
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancun Zhang, Yingjun Zhang, Hongming Xie, Qingyun Ren, Huichao Luo, Tianzhu Yu, Yumei Tan